HK Stock MarketDetailed Quotes

TRAD CHI MED (00570)

Watchlist

2.170
-0.010-0.46%

Trading Jan 16 14:33 CST

10.93BMarket Cap-37.41P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TRAD CHI MED (00570) Income Statement

All

YOY

Hide blank lines

(Q6)Jun 30, 2025

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

Turnover

-11.00%7.46B

-8.90%16.51B

-9.86%8.39B

26.69%18.12B

57.37%9.3B

-24.92%14.3B

-27.46%5.91B

28.68%19.05B

22.45%8.15B

3.39%14.81B

Operating income

-11.00%7.46B

-8.90%16.51B

-9.86%8.39B

26.69%18.12B

57.37%9.3B

-24.92%14.3B

-27.46%5.91B

28.68%19.05B

22.45%8.15B

3.39%14.81B

Cost of sales

11.46%-3.83B

2.19%-8.65B

4.86%-4.32B

-24.51%-8.85B

-53.56%-4.54B

1.63%-7.11B

5.94%-2.96B

-27.17%-7.22B

-19.26%-3.15B

1.13%-5.68B

Operating expenses

11.46%-3.83B

2.19%-8.65B

4.86%-4.32B

-24.51%-8.85B

-53.56%-4.54B

1.63%-7.11B

5.94%-2.96B

-27.17%-7.22B

-19.26%-3.15B

1.13%-5.68B

Gross profit

-10.51%3.63B

-15.29%7.86B

-14.64%4.06B

28.84%9.27B

61.19%4.76B

-39.15%7.2B

-41.00%2.95B

29.62%11.83B

24.54%5B

6.42%9.13B

Selling expenses

7.13%-2.56B

15.37%-5.42B

13.63%-2.75B

-39.08%-6.4B

-85.61%-3.19B

39.28%-4.6B

43.58%-1.72B

-35.71%-7.58B

-24.58%-3.04B

-9.35%-5.59B

Administrative expenses

2.27%-500.54M

-1.38%-1.06B

-10.20%-512.15M

-10.47%-1.04B

-15.72%-464.75M

3.08%-944.4M

-5.77%-401.61M

-37.77%-974.45M

-13.79%-379.7M

-3.07%-707.28M

Research and development expenses

4.40%-256.12M

13.07%-596.01M

14.57%-267.93M

-12.06%-685.63M

1.23%-313.61M

11.90%-611.83M

-7.75%-317.53M

-26.15%-694.44M

-20.13%-294.7M

-18.64%-550.47M

Impairment and provision

-17.07%-185.88M

-1,037.67%-106.55M

-232.37%-158.77M

7.02%-9.37M

-29.33%-47.77M

27.42%-10.07M

20.19%-36.94M

74.17%-13.88M

-39.65%-46.28M

-198.32%-53.73M

-Other impairment is provision

-17.07%-185.88M

-1,037.67%-106.55M

-232.37%-158.77M

7.02%-9.37M

-29.33%-47.77M

27.42%-10.07M

20.19%-36.94M

74.17%-13.88M

-39.65%-46.28M

-198.32%-53.73M

Special items of operating profit

-1,255.45%-171.34M

-215.94%-341.22M

-78.55%14.83M

712.16%294.3M

-24.19%69.13M

-80.79%36.24M

18.56%91.19M

-28.22%188.63M

-47.42%76.91M

61.93%262.77M

Operating profit

-109.28%-35.69M

-76.49%335.59M

-52.76%384.58M

34.11%1.43B

42.82%814.05M

-61.34%1.06B

-56.68%569.97M

10.54%2.75B

18.73%1.32B

1.22%2.49B

Financing cost

43.99%-47.2M

13.82%-171.54M

20.07%-84.27M

9.81%-199.05M

-6.97%-105.44M

0.60%-220.7M

10.34%-98.57M

9.25%-222.03M

2.63%-109.93M

18.73%-244.67M

Share of profits of associates

94.62%-47K

74.32%-950K

51.34%-874K

-6.32%-3.7M

-9.51%-1.8M

67.63%-3.48M

79.00%-1.64M

32.29%-10.75M

-60.66%-7.81M

-214.27%-15.87M

Earning before tax

-127.70%-82.94M

-86.68%163.11M

-57.64%299.43M

45.76%1.22B

50.46%706.81M

-66.67%840.11M

-60.78%469.77M

13.01%2.52B

20.96%1.2B

3.50%2.23B

Tax

31.03%-58.82M

-182.98%-142.34M

5.08%-85.29M

243.97%171.54M

-86.30%-89.85M

69.98%-119.14M

74.78%-48.23M

-7.42%-396.86M

-19.40%-191.24M

3.11%-369.45M

After-tax profit from continuing operations

-166.20%-141.76M

-98.51%20.77M

-65.29%214.14M

93.64%1.4B

46.36%616.96M

-66.05%720.97M

-58.13%421.54M

14.12%2.12B

21.26%1.01B

4.93%1.86B

Earning after tax

-166.20%-141.76M

-98.51%20.77M

-65.29%214.14M

93.64%1.4B

46.36%616.96M

-66.05%720.97M

-58.13%421.54M

14.12%2.12B

21.26%1.01B

4.93%1.86B

Minority profit

-1,169.60%-33.84M

-130.03%-33.3M

-91.72%3.16M

354.75%110.87M

380.91%38.22M

-122.84%-43.52M

-89.66%7.95M

-3.46%190.57M

-21.72%76.85M

6.59%197.39M

Profit attributable to shareholders

-151.15%-107.92M

-95.79%54.07M

-63.55%210.98M

68.11%1.29B

39.93%578.74M

-60.45%764.49M

-55.52%413.59M

16.21%1.93B

27.02%929.83M

4.73%1.66B

Basic earnings per share

-151.07%-0.0214

-95.81%0.0107

-63.53%0.0419

68.12%0.2552

39.95%0.1149

-60.45%0.1518

-55.53%0.0821

16.20%0.3838

26.96%0.1846

4.72%0.3303

Diluted earnings per share

-151.07%-0.0214

-95.81%0.0107

-63.53%0.0419

68.12%0.2552

39.95%0.1149

-60.45%0.1518

-55.53%0.0821

16.20%0.3838

26.96%0.1846

0.3303

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

Ernst & Young Accounting Firm

Ernst & Young

Deloitte Guan Huang Chen Fang Certified Public Accountants

	(Q6)Jun 30, 2025	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020
Turnover	-11.00%7.46B	-8.90%16.51B	-9.86%8.39B	26.69%18.12B	57.37%9.3B	-24.92%14.3B	-27.46%5.91B	28.68%19.05B	22.45%8.15B	3.39%14.81B
Operating income	-11.00%7.46B	-8.90%16.51B	-9.86%8.39B	26.69%18.12B	57.37%9.3B	-24.92%14.3B	-27.46%5.91B	28.68%19.05B	22.45%8.15B	3.39%14.81B
Cost of sales	11.46%-3.83B	2.19%-8.65B	4.86%-4.32B	-24.51%-8.85B	-53.56%-4.54B	1.63%-7.11B	5.94%-2.96B	-27.17%-7.22B	-19.26%-3.15B	1.13%-5.68B
Operating expenses	11.46%-3.83B	2.19%-8.65B	4.86%-4.32B	-24.51%-8.85B	-53.56%-4.54B	1.63%-7.11B	5.94%-2.96B	-27.17%-7.22B	-19.26%-3.15B	1.13%-5.68B
Gross profit	-10.51%3.63B	-15.29%7.86B	-14.64%4.06B	28.84%9.27B	61.19%4.76B	-39.15%7.2B	-41.00%2.95B	29.62%11.83B	24.54%5B	6.42%9.13B
Selling expenses	7.13%-2.56B	15.37%-5.42B	13.63%-2.75B	-39.08%-6.4B	-85.61%-3.19B	39.28%-4.6B	43.58%-1.72B	-35.71%-7.58B	-24.58%-3.04B	-9.35%-5.59B
Administrative expenses	2.27%-500.54M	-1.38%-1.06B	-10.20%-512.15M	-10.47%-1.04B	-15.72%-464.75M	3.08%-944.4M	-5.77%-401.61M	-37.77%-974.45M	-13.79%-379.7M	-3.07%-707.28M
Research and development expenses	4.40%-256.12M	13.07%-596.01M	14.57%-267.93M	-12.06%-685.63M	1.23%-313.61M	11.90%-611.83M	-7.75%-317.53M	-26.15%-694.44M	-20.13%-294.7M	-18.64%-550.47M
Impairment and provision	-17.07%-185.88M	-1,037.67%-106.55M	-232.37%-158.77M	7.02%-9.37M	-29.33%-47.77M	27.42%-10.07M	20.19%-36.94M	74.17%-13.88M	-39.65%-46.28M	-198.32%-53.73M
-Other impairment is provision	-17.07%-185.88M	-1,037.67%-106.55M	-232.37%-158.77M	7.02%-9.37M	-29.33%-47.77M	27.42%-10.07M	20.19%-36.94M	74.17%-13.88M	-39.65%-46.28M	-198.32%-53.73M
Special items of operating profit	-1,255.45%-171.34M	-215.94%-341.22M	-78.55%14.83M	712.16%294.3M	-24.19%69.13M	-80.79%36.24M	18.56%91.19M	-28.22%188.63M	-47.42%76.91M	61.93%262.77M
Operating profit	-109.28%-35.69M	-76.49%335.59M	-52.76%384.58M	34.11%1.43B	42.82%814.05M	-61.34%1.06B	-56.68%569.97M	10.54%2.75B	18.73%1.32B	1.22%2.49B
Financing cost	43.99%-47.2M	13.82%-171.54M	20.07%-84.27M	9.81%-199.05M	-6.97%-105.44M	0.60%-220.7M	10.34%-98.57M	9.25%-222.03M	2.63%-109.93M	18.73%-244.67M
Share of profits of associates	94.62%-47K	74.32%-950K	51.34%-874K	-6.32%-3.7M	-9.51%-1.8M	67.63%-3.48M	79.00%-1.64M	32.29%-10.75M	-60.66%-7.81M	-214.27%-15.87M
Earning before tax	-127.70%-82.94M	-86.68%163.11M	-57.64%299.43M	45.76%1.22B	50.46%706.81M	-66.67%840.11M	-60.78%469.77M	13.01%2.52B	20.96%1.2B	3.50%2.23B
Tax	31.03%-58.82M	-182.98%-142.34M	5.08%-85.29M	243.97%171.54M	-86.30%-89.85M	69.98%-119.14M	74.78%-48.23M	-7.42%-396.86M	-19.40%-191.24M	3.11%-369.45M
After-tax profit from continuing operations	-166.20%-141.76M	-98.51%20.77M	-65.29%214.14M	93.64%1.4B	46.36%616.96M	-66.05%720.97M	-58.13%421.54M	14.12%2.12B	21.26%1.01B	4.93%1.86B
Earning after tax	-166.20%-141.76M	-98.51%20.77M	-65.29%214.14M	93.64%1.4B	46.36%616.96M	-66.05%720.97M	-58.13%421.54M	14.12%2.12B	21.26%1.01B	4.93%1.86B
Minority profit	-1,169.60%-33.84M	-130.03%-33.3M	-91.72%3.16M	354.75%110.87M	380.91%38.22M	-122.84%-43.52M	-89.66%7.95M	-3.46%190.57M	-21.72%76.85M	6.59%197.39M
Profit attributable to shareholders	-151.15%-107.92M	-95.79%54.07M	-63.55%210.98M	68.11%1.29B	39.93%578.74M	-60.45%764.49M	-55.52%413.59M	16.21%1.93B	27.02%929.83M	4.73%1.66B
Basic earnings per share	-151.07%-0.0214	-95.81%0.0107	-63.53%0.0419	68.12%0.2552	39.95%0.1149	-60.45%0.1518	-55.53%0.0821	16.20%0.3838	26.96%0.1846	4.72%0.3303
Diluted earnings per share	-151.07%-0.0214	-95.81%0.0107	-63.53%0.0419	68.12%0.2552	39.95%0.1149	-60.45%0.1518	-55.53%0.0821	16.20%0.3838	26.96%0.1846	0.3303
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	Ernst & Young	--	Ernst & Young Accounting Firm	--	Ernst & Young Accounting Firm	--	Ernst & Young	--	Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol 5D % Chg

Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.

Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More

年頭旺到年尾

Aug 21, 2025 06:11

Are you foolish? What's the point of knowing your mistakes?

牛牛課堂

Sep 12, 2025 17:29

[Opportunity Express] With stock prices soaring, should SMIC "take profits and exit" or "patiently hold on"?